SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego ...
Novel compound attacks tuberculosis bacteria's ATP synthase, showing promise against drug resistance
Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...
Study Finds on MSN
Childhood virus linked to bladder cancer decades later
BKPyV infection is often asymptomatic or mild during childhood, but may leave a lasting impact on cancer risk. In A Nutshell ...
News-Medical.Net on MSN
New combination treatment offers significant benefits for people with recurring grade 3 astrocytoma
Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results